| References: 1] Ahmad, T., Murad, M. A., Nasir, S., Musa, T. H., Baig, M., Hui, J. (2021). Trends in hepatitis A research indexed in the Web of Science: A bibliometric analysis from 1985 to 2019. Human Vaccines & Immunotherapeutics, 17(9), 3221–3229. https://doi.org/10.1080/21645515.2021.1914804
[2] Chen, S., Mao, W., Guo, L., Zhang, J., Tang, S. (2020). Combating hepatitis B and C by 2030: Achievements, gaps, and action options in China. BMJ Global Health, 5(6), e002306. https://doi.org/10.1136/bmjgh-2020-002306
[3] Conners, E. E. (2023). Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023. MMWR. Recommendations and Reports, 72. https://doi.org/10.15585/mmwr.rr7201a1
[4] Gerlich, W. H. (2013). Medical Virology of Hepatitis B: How it began and where we are now. Virology Journal, 10(1), 239. https://doi.org/10.1186/1743-422X-10-239
[5] Hoofnagle, J. H., Doo, E., Liang, T. J., Fleischer, R., Lok, A. S. F. (2007). Management of hepatitis B: Summary of a clinical research workshop. Hepatology, 45(4), 1056–1075. https://doi.org/10.1002/hep.21627
[6] Hu, J., Protzer, U., Siddiqui, A. (2019). Revisiting Hepatitis B Virus: Challenges of Curative Therapies. Journal of Virology, 93(20), 10.1128/jvi.01032-19. https://doi.org/10.1128/jvi.01032-19
[7] Hutin, Y., Nasrullah, M., Easterbrook, P., Dongmo Nguimfack, B., Burrone, E., Averhoff, F., Bulterys, M. (2018). Access to treatment for hepatitis B virus infection—Worldwide, 2016. American Journal of Transplantation, 18(10), 2595–2598. https://doi.org/10.1111/ajt.15093
[8] Kim, W. R. (2009). Epidemiology of hepatitis B in the United States. Hepatology, 49(S5), S28– S34. https://doi.org/10.1002/hep.22975
[9] Kruszon-Moran, D., Paulose-Ram, R., Martin, C. B., Barker, L. K., McQuillan, G. (2020). Prevalence and trends in hepatitis B virus infection in the United States, 2015–2018. https://stacks.cdc.gov/view/cdc/86200
[10] Li, M., Sohn, J. A., Seeger, C. (2017). Distribution of Hepatitis B Virus Nuclear DNA. Journal of Virology, 92(1), 10.1128/jvi.01391-17. https://doi.org/10.1128/jvi.01391-17
[11] Liang, T. J. (2009). Hepatitis B: The virus and disease. Hepatology, 49(S5), S13–S21. https://doi.org/10.1002/hep.22881
[12] Liu, S., Zhou, B., Valdes, J. D., Sun, J., Guo, H. (2019a). Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection. Hepatology, 69(4), 1816– 1827. https://doi.org/10.1002/hep.30325
[13] Liu, S., Zhou, B., Valdes, J. D., Sun, J., Guo, H. (2019b). Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection. Hepatology, 69(4), 1816– 1827. https://doi.org/10.1002/hep.30325
[14] Lok, A. S. F., McMahon, B. J. (2004). Chronic hepatitis B: Update of recommendations.Hepatology, 39(3), 857–861. https://doi.org/10.1002/hep.20110
[15] Lok, A. S. F., McMahon, B. J. (2007a). Chronic hepatitis B. Hepatology, 45(2), 507–539. https://doi.org/10.1002/hep.21513
[16] MacLachlan, J. H., Cowie, B. C. (2015). Hepatitis B Virus Epidemiology. Cold Spring Harbor Perspectives in Medicine, 5(5), a021410. https://doi.org/10.1101/cshperspect.a021410
[17] Mak, L.-Y., Wong, D. K.-H., Pollicino, T., Raimondo, G., Hollinger, F. B., Yuen, M.-F. (2020). Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance. Journal of Hepatology, 73(4), 952–964. https://doi.org/10.1016/j.jhep.2020.05.042
[18] Marcellin, P. (2009). Hepatitis B and hepatitis C in 2009. Liver International, 29(s1), 1–8. https://doi.org/10.1111/j.1478-3231.2008.01947.x
[19] Naga, S., S., V., Rajendran, D. (2019). Global Research Publications on Hepatitis C from SCOPUS Database (2009-2018): A Scientometric Study. Library Philosophy and Practice, 2019.
[20] Nguyen, M. H., Wong, G., Gane, E., Kao, J.-H., Dusheiko, G. (2020). Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clinical Microbiology Reviews, 33(2), 10.1128/cmr.00046-19. https://doi.org/10.1128/cmr.00046-19
[21] Patel, E. U., Thio, C. L., Boon, D., Thomas, D. L., Tobian, A. A. R. (2019). Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011–2016. Clinical Infectious Diseases, 69(4), 709–712. https://doi.org/10.1093/cid/ciz001
[22] Popa, G. L., Popa, M. I. (2022). Oxidative Stress in Chronic Hepatitis B—An Update. Microorganisms, 10(7), Article 7. https://doi.org/10.3390/microorganisms10071265’
[23] Sangam, S. L. (n.d.). Librametry, Bibliometrics, Scientometrics, Informetrics and Webometrics: Historical Development. e-PG Pathshala. https://epgp.inflibnet.ac.in
[24] Schmidt, S., Bundschuh, M., Scutaru, C., Klingelhoefer, D., Groneberg, D. A., Gerber, A. (2014). Hepatitis B: Global scientific development from a critical point of view. Journal of Viral Hepatitis, 21(11), 786–793. https://doi.org/10.1111/jvh.12205
[25] Sheena, B. S., Hiebert, L., Han, H., Ippolito, H., Abbasi-Kangevari, M., Abbasi-Kangevari, Z., Abbastabar, H., Abdoli, A., Ali, H. A., Adane, M. M., Adegboye, O. A., Adnani, Q. E. S., Advani, S. M., Afzal, M. S., Afzal, S., Meybodi, M. A., Ahadinezhad, B., Ahinkorah, B. O., Ahmad, S., … Dirac, M. A. (2022). Global, regional, and national burden of hepatitis B, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet Gastroenterology & Hepatology, 7(9), 796–829. https://doi.org/10.1016/S2468-
[26] Z., Yang, L., Chen, Y., Chen, Z., Liu, J., Jiang, J., Zhu, L., Zhai, X., Jiang, Y., … for the China Kadoorie Biobank Collaborative Group. (2019). Associations Between Hepatitis B Virus Infection and Risk of All Cancer Types. JAMA Network Open, 2(6), e195718. https://doi.org/10.1001/jamanetworkopen.2019.5718
[27] Sperle, I., Steffen, G., Leendertz, S. A., Sarma, N., Beermann, S., Thamm, R., Simeonova, Y., Cornberg, M., Wedemeyer, H., Bremer, V., Zimmermann, R., Dudareva, S. (2020). Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review. Frontiers in Public Health, 8. https://doi.org/10.3389/fpubh.2020.00424
[28] Tan, G., Song, H., Xu, F., Cheng, G. (2018). When Hepatitis B Virus Meets Interferons.
[29] Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K.-M., Hwang, J. P., Jonas, M. M., Brown Jr., R. S., Bzowej, N. H., Wong, J. B. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology, 67(4), 1560–1599. https://doi.org/10.1002/hep.29800
[30] Wang, H., Men, P., Xiao, Y., Gao, P., Lv, M., Yuan, Q., Chen, W., Bai, S., Wu, J. (2019).
[31] Hepatitis B infection in the general population of China: A systematic review and meta- analysis. BMC Infectious Diseases, 19(1), 811. https://doi.org/10.1186/s12879-019-4428-y Wani, Z. A., Kharadi, A. H. (2017). Bibliometric Analysis of’ Hepatitis E’Literature. International Journal of Information Dissemination & Technology, 7(4). https://www.researchgate.net/prof ile/Aabid- Kharadi/publica tion/329121750_Bibliometric_analys is_of_’hepatitis_e_’literature/links/5f 1acca145851515ef44de0c/Bibliometric-analysis-of-hepatitis-e-literature.pdf
[32] Wong, G. L.-H. (2018). Management of chronic hepatitis B patients in immunetolerant phase: What latest guidelines recommend. Clinical and Molecular Hepatology, 24(2), 108–113. https://doi.org/10.3350/cmh.2017.0068
[33] Yim, S. Y., Kim, J. H. (2019). The epidemiology of hepatitis B virus infection in Korea. The Korean Journal of Internal Medicine, 34(5), 945–953. https://doi.org/10.3904/kjim.2019.007
|
